214-221
Antihyperglycemic and subchronic toxicity study of Moringa stenopetala leaves in mice
Authors: Tesemma Sileshi, Eyasu Makonnen, Asfaw Debella, Birhanu Tesfaye
Number of views: 318
Objective: To evaluate the antihyperglycemic activity and subchronic toxicity of an extract of
Moringa stenopetala (M. stenopetala) leaves in mice.
Methods: Antihyperglycemic activities of various solvent subfractions and chromatographic
fractions were investigated in alloxan induced diabetic mice. All fractions were administered
intragastrically using oral gavage at a dose of 500 mg/kg. For the subchronic toxicity investigation
of the 70% ethanol extract of M. stenopetala leaves, a daily dose of 300 or 600 mg/kg body weight
was administered to mice over 96 d. Some hematological and plasma biochemical parameters
were measured as indices of organ specific toxicity. Preliminary phytochemical screening and
antioxidant activity investigation was done using thin layer chromatography method.
Results: Among the solvent subfractions of the 70% ethanol extract tested only butanol subfraction
exhibited significant reduction of blood glucose level (P<0.05) at 2 h (53.44%) and 4.5 h (46.34%) in
diabetic mice and it was further fractionated chromatographically. This resulted in isolation of three
chromatographic fractions (fraction 1, 2, and 3) which exhibited maximal blood glucose reduction
(P<0.01) at 6 h (77.2%), at 4.5 h (69.1%) and at 4.5 h (71.96%) after administration. Furthermore, these
fractions exhibited comparable antioxidant activity, and preliminary phytochemical screening
indicated the presence of phenolic compounds which may be phenolic glycoside in all fractions. The
subchronic toxicity study of the 70% ethanol extract of M. stenopetala leaves revealed that there were
no significant differences in body weight, between controls and treated mice. Hematological analysis
showed no differences in most parameters examined. Furthermore, it did not significantly affect
plasma creatinine, urea, cholesterol, triglycerides and CA125 levels. It also did not significantly
affect the plasma T3, T4 and THS level. It, however, caused a significant dose-dependent increases
in aspartate aminotransferase and alkaline phosphatase. The plasma alanine aminotransferase
increased in a dose dependent manner, though not significant.
Conclusions: The present study revealed that the crude ethanol extract and solvent-solvent
fractions as well as chromatographic fractions have antihyperglycemic effect. Furthermore,
the crude ethanol extract have some effect on liver of the mice on subchronic administration.
Therefore, further study should be done to identify the active principal compound responsible for
antihyperglycemic effect and to rule out the safety in other animal model.